Tejnaksh Healthcare’s research lab gets renewal of DSIR approval

05 Apr 2025 Evaluate

Tejnaksh Healthcare’s research lab has been granted renewed approval by the Department of Scientific and Industrial Research (DSIR) for the next two years. This approval not only reinforces its position as a leader in the healthcare and research domain but also enhances the credibility of the work the company do in partnership with its collaborators and research teams.

The DSIR’s recognition underscores the importance of translational research and its application in improving healthcare practices on a global scale. 

Tejnaksh Healthcare owns and operates a hospital under the brand name of the Institute of Urology.

Tejnaksh Healthcare Share Price

14.72 0.01 (0.07%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7235.90
Max Healthcare Inst 1036.55
Narayana Hrudayalay 1918.80
Aster DM Healthcare 599.60
Global Health 1144.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×